Publication | Closed Access

Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial

UrologyGenitourinary CancerGetug-afu15 TrialMedicineAndrogen Deprivation TherapyProstatic DiseaseOncologyRadiation OncologyEndocrine-related CancerMetastatic Burden